Evidence map›Paper›PMID 38164232›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2024

Unmasking Coincident Hodgkin Lymphoma and Giant Cell Tumor: Insights from [

Akram Al-Ibraheem, Serin Moghrabi, Ahmed Saad Abdlkadir, Mohamad Haidar, Omar Jaber

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Serin MoghrabiDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Mohamad HaidarDepartment of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Omar JaberDepartment of pathology, King Hussein Cancer Center (KHCC), Amman, Jordan.
King Hussein Cancer Center · JOAmerican University of Beirut Medical Center · LBUniversity of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tenosynovial giant cell tumors represent a group of typically non-malignant tumors found within the joints and soft tissues. The occurrence of tenosynovial giant cell tumor alongside hematologic malignancies is an infrequent finding. Herein, we report a patient who presented with coinciding Hodgkin Lymphoma (HL) and tenosynovial giant cell tumor before chemotherapy initiation. The case was discovered during initial assessment using [

Indexed as

Giant Cell TumorHodgkin LymphomaPET/CTSynchronous Giant Cell Tumor

Identifiers

PMID38164232
PMCPMC10757054
OpenAlexW4390507743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.